Clinical Trial Update: Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH) [Phase 1]

View source ↗

Summary

A Phase 1 safety trial evaluating PLX-PAD cells for pulmonary arterial hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• PLX-PAD Cells (PLX-PAD)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: TERMINATED